Answers are grounded in this paper and cite their sources.
Canagliflozin provided reductions in HbA1c, body weight, and insulin dose with no increase in hypoglycemia, but increased rates of ketone-related AEs, including DKA, in adults with type 1 diabetes inadequately controlled with insulin.
No takes yet. Share an insight, caveat, or question.
Henry et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: